Skip to main content

Table 1 Clinicopathological data of the IDH mutant versus wild-type group

From: IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas

 

IDH wild-type (n = 29)

IDH mutation (n = 45)

Male

9 (31%)

19 (42%)

Median age at diagnosis

51 (21–79)

51 (22–85)

Histology

 Enchondroma

1 (15%)

6 (85%)

 ACT/grade I

14 (50%)

14 (50%)

 Grade II

9 (34%)

18 (66%)

 Grade III

5 (42%)

7 (58%)

 Metastasis

4 (45%)

5 (55%)

Median follow-up (months)

137 (7–278)

121 (11–312)

  1. ACT atypical cartilaginous tumour
Back to article page

Clinical Sarcoma Research

ISSN: 2045-3329